November/December 2012

Robert L. Avery, MD; and Allen C. Ho, MD

The Game Changers of 2012

Genetic Testing for Inherited Eye Disease Called Into Question

Should patients with age-related macular degeneration undergo genetic analysis?

Callan Navitsky, Associate Editor

The Regulation of Compounding Pharmacies

The recent outbreak of fungal meningitis emphasizes the need for more efficient oversight.

Callan Navitsky, Associate Editor

One Year After Aflibercept: Where Are We With Therapeutic Approaches for Retinal Vascular Diseases?

Aron Shapiro with David Boyer, MD, and Quan Dong Nguyen, MD, MSC

Making the Most of Your Vitreoretinal Fellowship: Part 1

Advice from senior attendings.

Adam Gerstenblith, MD; Char DeCroos, MD; and Rajiv Shah, MD

Surgery for Macular Hole and Retinal Detachment

The coexistence of these conditions must be addressed with a specific surgical approach.

Roberto Alejandro Guerra Garcí,a, MD

Subretinal Bands in Proliferative Vitreoretinopathy

Emmanuel y. Chang, MD, PhD, and George a. Williams, MD

Visual Outcome after Intravenous Chemotherapy for Retinoblastoma

Anthony M. Parendo, BS; Phoebe L. Mellen, BS; and Carol L. Shields, MD

Thoughts Concerning Anti-VEGF Treatment for Radiation Retinopathy and Radiation Optic Neuropathy

Paul T. Finger, MD, FACS

Treatment of Retinoblastoma in the First 3 Months of Life: Bridge Therapy

David H. Abramson, MD, FACS

Unique Challenges of Ocular Oncology

With J. William Harbour, MD

Retinoblastoma 2012

Amy C. Schefler, MD

Starting a Private Ocular Oncology Practice

After decades in academia, the author ventured into private practice.

Timothy G. Murray, MD, MBA, FACS

Future Therapies for Chronic Noninfectious Uveitis

New drugs and innovative drug delivery systems will pave the way for future treatments in uveitis.

Emmett T. Cunningham, Jr, MD, PhD, MPH

Investing in Technology for a Diagnostic Payoff

The CX-1 camera has helped improve patient workflow with high-quality imaging.

Neil F. Notaroberto, MD

Electronic Health Records in Practice

Adoption of EHR has far greater rewards for a practice than just a government incentive check.

David M. Misch, MD, MBA

5Q With Jeffrey S. Heier, MD

Dr. Heier is Director of the Vitreoretinal Service at Ophthalmic Consultants of Boston (OCB), and Director of Retinal Research and Codirector of the Vitreoretinal Fellowship at OCB/Tufts Medical School in Boston. He is a member of the Retina Today editorial board.